BIOLASE Long Term Debt Total vs Capital Surpluse Analysis

BIOL Stock

USD 0.15 0.01 7.14%

BIOLASE financial indicator trend analysis is way more than just evaluating BIOLASE prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether BIOLASE is a good investment. Please check the relationship between BIOLASE Long Term Debt Total and its Capital Surpluse accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BIOLASE. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons.

For more information on how to buy BIOLASE Stock please use our How to buy in BIOLASE Stock guide.

Long Term Debt Total vs Capital Surpluse

Long Term Debt Total vs Capital Surpluse Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of BIOLASE Long Term Debt Total account and Capital Surpluse. At this time, the significance of the direction appears to have almost identical trend.

The correlation between BIOLASE's Long Term Debt Total and Capital Surpluse is 0.94. Overlapping area represents the amount of variation of Long Term Debt Total that can explain the historical movement of Capital Surpluse in the same time period over historical financial statements of BIOLASE, assuming nothing else is changed. The correlation between historical values of BIOLASE's Long Term Debt Total and Capital Surpluse is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Long Term Debt Total of BIOLASE are associated (or correlated) with its Capital Surpluse. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capital Surpluse has no effect on the direction of Long Term Debt Total i.e., BIOLASE's Long Term Debt Total and Capital Surpluse go up and down completely randomly.

Correlation Coefficient

0.94

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Long Term Debt Total

Capital Surpluse

Most indicators from BIOLASE's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into BIOLASE current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BIOLASE. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons.

For more information on how to buy BIOLASE Stock please use our How to buy in BIOLASE Stock guide.At this time, BIOLASE's Selling General Administrative is quite stable compared to the past year. Tax Provision is expected to rise to about 138.6 K this year, although the value of Sales General And Administrative To Revenue will most likely fall to 0.20.

	2021	2022	2023	2024 (projected)
Gross Profit	16.5M	15.9M	16.7M	17.3M
Total Revenue	39.2M	48.5M	49.2M	38.5M

Gross Profit Total Revenue

BIOLASE fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock Total Equity	Common Stock
Total Assets		0.12	0.52	0.28	0.73	0.1	-0.61	-0.44	0.32	0.82	0.4	0.2	0.82	0.26	-0.12	0.22	0.76	0.53	0.53	0.4	-0.05	0.99	-0.24	0.17	0.42	0.6
Short Long Term Debt Total	0.12		0.67	0.11	-0.46	0.57	0.54	-0.87	-0.45	0.1	0.4	-0.34	0.12	-0.39	0.56	0.88	0.16	0.43	0.83	0.68	0.58	0.06	0.22	0.83	0.68	0.03
Other Current Liab	0.52	0.67		0.34	-0.09	0.7	0.27	-0.88	0.09	0.22	0.71	0.01	0.23	0.06	0.46	0.74	0.63	0.6	0.89	0.71	0.55	0.42	-0.13	0.62	0.68	0.02
Total Current Liabilities	0.28	0.11	0.34		-0.11	0.08	0.22	-0.34	0.68	-0.15	0.38	0.24	-0.16	0.64	0.06	-0.04	0.62	0.22	0.31	0.59	0.07	0.23	0.65	0.09	-0.05	-0.19
Total Stockholder Equity	0.73	-0.46	-0.09	-0.11		-0.29	-0.96	0.22	0.3	0.73	-0.02	0.27	0.71	0.31	-0.46	-0.38	0.38	0.12	-0.1	-0.28	-0.42	0.78	-0.48	-0.32	0.03	0.64
Property Plant And Equipment Net	0.1	0.57	0.7	0.08	-0.29		0.43	-0.74	-0.03	-0.09	0.77	0.13	-0.06	-0.22	0.78	0.57	0.23	0.22	0.74	0.34	0.89	-0.03	-0.12	0.63	0.81	-0.24
Net Debt	-0.61	0.54	0.27	0.22	-0.96	0.43		-0.37	-0.18	-0.75	0.21	-0.2	-0.74	-0.16	0.48	0.43	-0.16	0.05	0.25	0.38	0.48	-0.69	0.43	0.42	0.09	-0.63
Retained Earnings	-0.44	-0.87	-0.88	-0.34	0.22	-0.74	-0.37		0.11	-0.23	-0.7	0.0	-0.25	0.16	-0.56	-0.84	-0.51	-0.52	-0.99	-0.79	-0.64	-0.34	-0.14	-0.82	-0.77	-0.05
Accounts Payable	0.32	-0.45	0.09	0.68	0.3	-0.03	-0.18	0.11		-0.1	0.25	0.26	-0.11	0.81	-0.08	-0.45	0.55	0.12	-0.08	0.06	-0.06	0.29	0.08	-0.32	-0.2	-0.21
Cash	0.82	0.1	0.22	-0.15	0.73	-0.09	-0.75	-0.23	-0.1		0.01	-0.02	1.0	-0.17	-0.11	0.24	0.3	0.27	0.33	0.14	-0.12	0.87	-0.31	0.08	0.35	0.7
Non Current Assets Total	0.4	0.4	0.71	0.38	-0.02	0.77	0.21	-0.7	0.25	0.01		0.32	0.01	0.07	0.39	0.42	0.67	0.45	0.69	0.59	0.54	0.24	-0.12	0.49	0.67	-0.01
Non Currrent Assets Other	0.2	-0.34	0.01	0.24	0.27	0.13	-0.2	0.0	0.26	-0.02	0.32		-0.02	0.36	-0.15	-0.29	0.27	-0.19	0.03	-0.07	-0.04	0.15	0.06	-0.08	-0.07	0.07
Cash And Short Term Investments	0.82	0.12	0.23	-0.16	0.71	-0.06	-0.74	-0.25	-0.11	1.0	0.01	-0.02		-0.18	-0.08	0.26	0.28	0.27	0.35	0.13	-0.09	0.86	-0.3	0.1	0.37	0.69
Net Receivables	0.26	-0.39	0.06	0.64	0.31	-0.22	-0.16	0.16	0.81	-0.17	0.07	0.36	-0.18		-0.25	-0.52	0.48	0.01	-0.13	-0.02	-0.24	0.27	0.15	-0.27	-0.36	-0.1
Common Stock Shares Outstanding	-0.12	0.56	0.46	0.06	-0.46	0.78	0.48	-0.56	-0.08	-0.11	0.39	-0.15	-0.08	-0.25		0.51	-0.17	-0.13	0.55	0.21	0.98	-0.19	0.11	0.45	0.59	-0.42
Non Current Liabilities Total	0.22	0.88	0.74	-0.04	-0.38	0.57	0.43	-0.84	-0.45	0.24	0.42	-0.29	0.26	-0.52	0.51		0.19	0.52	0.81	0.71	0.54	0.15	-0.05	0.72	0.65	0.05
Inventory	0.76	0.16	0.63	0.62	0.38	0.23	-0.16	-0.51	0.55	0.3	0.67	0.27	0.28	0.48	-0.17	0.19		0.72	0.54	0.63	-0.05	0.69	-0.06	0.21	0.32	0.28
Other Current Assets	0.53	0.43	0.6	0.22	0.12	0.22	0.05	-0.52	0.12	0.27	0.45	-0.19	0.27	0.01	-0.13	0.52	0.72		0.53	0.61	-0.03	0.48	-0.2	0.26	0.48	0.3
Other Stockholder Equity	0.53	0.83	0.89	0.31	-0.1	0.74	0.25	-0.99	-0.08	0.33	0.69	0.03	0.35	-0.13	0.55	0.81	0.54	0.53		0.73	0.64	0.44	0.07	0.8	0.81	0.12
Total Liab	0.4	0.68	0.71	0.59	-0.28	0.34	0.38	-0.79	0.06	0.14	0.59	-0.07	0.13	-0.02	0.21	0.71	0.63	0.61	0.73		0.25	0.32	0.32	0.56	0.38	0.04
Property Plant And Equipment Gross	-0.05	0.58	0.55	0.07	-0.42	0.89	0.48	-0.64	-0.06	-0.12	0.54	-0.04	-0.09	-0.24	0.98	0.54	-0.05	-0.03	0.64	0.25		-0.15	0.04	0.53	0.69	-0.39
Total Current Assets	0.99	0.06	0.42	0.23	0.78	-0.03	-0.69	-0.34	0.29	0.87	0.24	0.15	0.86	0.27	-0.19	0.15	0.69	0.48	0.44	0.32	-0.15		-0.23	0.09	0.32	0.64
Short Term Debt	-0.24	0.22	-0.13	0.65	-0.48	-0.12	0.43	-0.14	0.08	-0.31	-0.12	0.06	-0.3	0.15	0.11	-0.05	-0.06	-0.2	0.07	0.32	0.04	-0.23		0.12	-0.23	-0.29
Intangible Assets	0.17	0.83	0.62	0.09	-0.32	0.63	0.42	-0.82	-0.32	0.08	0.49	-0.08	0.1	-0.27	0.45	0.72	0.21	0.26	0.8	0.56	0.53	0.09	0.12		0.64	0.09
Common Stock Total Equity	0.42	0.68	0.68	-0.05	0.03	0.81	0.09	-0.77	-0.2	0.35	0.67	-0.07	0.37	-0.36	0.59	0.65	0.32	0.48	0.81	0.38	0.69	0.32	-0.23	0.64		0.26
Common Stock	0.6	0.03	0.02	-0.19	0.64	-0.24	-0.63	-0.05	-0.21	0.7	-0.01	0.07	0.69	-0.1	-0.42	0.05	0.28	0.3	0.12	0.04	-0.39	0.64	-0.29	0.09	0.26

Click cells to compare fundamentals

BIOLASE Account Relationship Matchups

BIOLASE fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	31.8M	41.0M	55.3M	38.2M	35.1M	31.3M
Short Long Term Debt Total	13.5M	18.0M	15.1M	15.1M	17.9M	18.8M
Other Current Liab	4.7M	6.4M	7.9M	9.2M	8.0M	8.4M
Total Current Liabilities	25.8M	11.2M	13.8M	17.8M	19.7M	14.3M
Total Stockholder Equity	377K	10.0M	25.2M	4.9M	(247K)	(234.7K)
Property Plant And Equipment Net	1.5M	2.8M	2.8M	6.0M	7.0M	7.4M
Net Debt	7.7M	396K	(14.9M)	10.9M	11.3M	11.9M
Retained Earnings	(234.5M)	(251.4M)	(267.5M)	(296.2M)	(316.8M)	(301.0M)
Accounts Payable	5.3M	2.7M	3.3M	5.8M	6.1M	4.9M
Cash	5.8M	17.6M	30.0M	4.2M	6.6M	7.9M
Non Current Assets Total	4.8M	5.9M	5.9M	9.2M	10.2M	5.7M
Non Currrent Assets Other	433K	231K	220K	255K	268K	277.2K
Cash And Short Term Investments	5.8M	17.6M	30.0M	4.2M	6.6M	9.6M
Net Receivables	8.8M	3.1M	4.2M	5.8M	5.5M	6.3M
Common Stock Shares Outstanding	9.3K	24.5K	59.1K	69.3K	1.3M	1.3M
Liabilities And Stockholders Equity	31.8M	41.0M	55.3M	38.2M	35.1M	31.3M
Non Current Liabilities Total	5.7M	19.8M	16.2M	15.5M	15.7M	16.5M
Inventory	11.0M	11.2M	12.9M	15.9M	11.4M	8.1M
Other Current Assets	1.2M	3.0M	2.0M	3.1M	1.4M	1.5M
Other Stockholder Equity	231.6M	261.6M	293.2M	301.8M	314.9M	330.6M
Total Liab	31.5M	31.0M	30.1M	33.3M	35.3M	18.3M
Property Plant And Equipment Gross	1.5M	2.8M	2.8M	6.0M	18.4M	19.3M
Total Current Assets	27.0M	35.1M	49.4M	29.0M	24.9M	25.5M
Accumulated Other Comprehensive Income	(701K)	(385K)	(623K)	(733K)	(553K)	(580.7K)
Short Term Debt	13.5M	305K	405K	700K	3.2M	2.9M
Common Stock Total Equity	102K	21K	31K	98K	112.7K	118.3K
Common Stock	31K	98K	154K	8K	3K	2.9K
Other Assets	433K	2.2M	220K	255K	229.5K	218.0K
Property Plant Equipment	1.2M	2.8M	2.8M	6.0M	7.0M	7.3M
Other Liab	1.7M	1.8M	1.2M	1.1M	1.0M	1.1M
Current Deferred Revenue	2.2M	1.9M	2.3M	2.1M	2.5M	2.3M
Net Tangible Assets	8.2M	1.4M	7.0M	22.2M	20.0M	12.3M
Retained Earnings Total Equity	(195.2M)	(216.7M)	(234.5M)	(251.4M)	(226.2M)	(237.6M)
Capital Surpluse	224.9M	228.4M	235.6M	261.6M	300.8M	214.9M
Deferred Long Term Liab	115K	77K	436K	374K	336.6K	368.5K
Non Current Liabilities Other	1.3M	1.1M	330K	362K	79K	75.1K

Pair Trading with BIOLASE

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if BIOLASE position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BIOLASE will appreciate offsetting losses from the drop in the long position's value.

Moving together with BIOLASE Stock

0.62

AHG

Akso Health Group

Pair Corr

Moving against BIOLASE Stock

0.68	TLIS	Talis Biomedical Corp	Pair Corr
0.62	TNDM	Tandem Diabetes Care	Pair Corr
0.58	SNDA	Sonida Senior Living	Pair Corr
0.52	DHR	Danaher Earnings Call This Week	Pair Corr
0.49	JYNT	Joint Corp Financial Report 2nd of May 2024	Pair Corr

The ability to find closely correlated positions to BIOLASE could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace BIOLASE when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back BIOLASE - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling BIOLASE to buy it.

The correlation of BIOLASE is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as BIOLASE moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if BIOLASE moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for BIOLASE can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether BIOLASE is a strong investment it is important to analyze BIOLASE's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact BIOLASE's future performance. For an informed investment choice regarding BIOLASE Stock, refer to the following important reports:

How To Invest In BIOLASE

Details

Is BIOLASE Stock a good investment?

Details

What is BIOLASE's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BIOLASE. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons.

For more information on how to buy BIOLASE Stock please use our How to buy in BIOLASE Stock guide.

You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.

Complementary Tools for BIOLASE Stock analysis

When running BIOLASE's price analysis, check to measure BIOLASE's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BIOLASE is operating at the current time. Most of BIOLASE's value examination focuses on studying past and present price action to predict the probability of BIOLASE's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BIOLASE's price. Additionally, you may evaluate how the addition of BIOLASE to your portfolios can decrease your overall portfolio volatility.

	Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk
	Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years
	Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
	Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
	Fundamental Analysis View fundamental data based on most recent published financial statements

Is BIOLASE's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BIOLASE. If investors know BIOLASE will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BIOLASE listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(29.44)

Revenue Per Share

38.469

Quarterly Revenue Growth

(0.04)

Return On Assets

(0.29)

Return On Equity

(6.03)

The market value of BIOLASE is measured differently than its book value, which is the value of BIOLASE that is recorded on the company's balance sheet. Investors also form their own opinion of BIOLASE's value that differs from its market value or its book value, called intrinsic value, which is BIOLASE's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BIOLASE's market value can be influenced by many factors that don't directly affect BIOLASE's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between BIOLASE's value and its price as these two are different measures arrived at by different means. Investors typically determine if BIOLASE is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BIOLASE's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

BIOLASE Long Term Debt Total vs Capital Surpluse Analysis

Long Term Debt Total vs Capital Surpluse

Long Term Debt Total vs Capital Surpluse Correlation Analysis

Correlation Coefficient

Long Term Debt Total

Capital Surpluse

BIOLASE fundamental ratios Correlations

BIOLASE Account Relationship Matchups

High Positive Relationship

High Negative Relationship

BIOLASE fundamental ratios Accounts

Pair Trading with BIOLASE

Moving together with BIOLASE Stock

Moving against BIOLASE Stock

Complementary Tools for BIOLASE Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Total Current Assets	+ 0.99	Total Assets
Property Plant And Equipment Gross	+ 0.98	Common Stock Shares Outstanding
Other Stockholder Equity	+ 0.89	Other Current Liab
Property Plant And Equipment Gross	+ 0.89	Property Plant And Equipment Net
Non Current Liabilities Total	+ 0.88	Short Long Term Debt Total

Other Stockholder Equity	- 0.99	Retained Earnings
Net Debt	- 0.96	Total Stockholder Equity
Retained Earnings	- 0.88	Other Current Liab
Retained Earnings	- 0.87	Short Long Term Debt Total
Non Current Liabilities Total	- 0.84	Retained Earnings
Intangible Assets	- 0.82	Retained Earnings